Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

PowderJect presents positive data using PowderJect DNA vaccine

April 8, 1999

Aquila reveals new product in pipeline: CD1-TB

April 5, 1999

Merck & Co. presents new macrolide immunosuppressants

April 1, 1999

Aquila initiates phase IIb testing of Quilimmune-P

April 1, 1999

New patent expands protection for BioTransplant's AlloMune and XenoMune systems

March 23, 1999

Collaboration between Wyeth and Aviron for FluMist effective immediately

March 23, 1999

German launch announced for Novartis immunosuppressant

March 22, 1999

Novel tacrolimus (FK-506) prodrug expected to have superior therapeutic activity

March 22, 1999

Antex Chlamydia vaccine shows promise in animal study

March 19, 1999

Immunomodulatory effects of sinomenine, an alkaloid compound of plant origin

March 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...